| Identification | Back Directory | [Name]
D,L-THREO-1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL | [CAS]
80938-69-8 | [Synonyms]
PDMP
DL-PDMP
DL-threo-PDMP
D,L-THREO-PDMP HCL
DL-THREO-PDMP, HYDROCHLORIDE
(+/-)-THREO-PDMP HYDROCHLORIDE
(+)-threo-1-phenyl-2-decanoylamino-3-*morpholino-
(±)-threo-PDMP hydrochloride, PDMP hydrochloride
(+)-THREO-1-PHENYL-2-DECANOYLAMINO-3-*MO RPHOLINO-1-
1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL, HCL
PDMP HYDROCHLORIDE \ GLUCOSYLCERAMIDE SY NTHASE INHIBITOR
(±)-threo-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol
DL-threo-PDMP, Hydrochloride - CAS 80938-69-8 - Calbiochem
D,L-THREO-1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HCL
N-[(1R,2R)-1-hydroxy-3-morpholin-4-yl-1-phenylpropan-2-yl]decanamide
(+/-)-threo-1-Phenyl-2-decanoylamino-3-morpholino-1-propanol hydrochloride
(+/-)-THREO-1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL HYDROCHLORIDE
N-[2-HYDROXY-1-(4-MORPHOLINYLMETHYL)-2-PHENYLETHYL]-DECANAMIDE, MONOHYDROCHLORIDE
N-[(1R,2R)-1-hydroxy-3-morpholin-4-yl-1-phenylpropan-2-yl]decanamide:hydrochloride | [Molecular Formula]
C23H39ClN2O3 | [MDL Number]
MFCD00236490 | [MOL File]
80938-69-8.mol | [Molecular Weight]
427.03 |
| Chemical Properties | Back Directory | [storage temp. ]
-20°C | [solubility ]
DMF: 25 mg/ml; DMSO: 30 mg/ml; Ethanol: 50 mg/ml; Ethanol:PBS (pH 7.2) (1:5): 0.05 mg/ml | [form ]
White solid | [color ]
white | [biological source]
synthetic (organic) | [Water Solubility ]
water: 50mg/mL, clear, colorless |
| Hazard Information | Back Directory | [Description]
DL-threo PDMP is a mixture of ceramide analogs that contains two of the four possible stereoisomers of PDMP : D-threo-(1R,2R)-PDMP and L-threo-(1S,2S)-PDMP. DL-threo-PDMP inhibits glucosylceramide synthase by 33 and 48% in MDCK cell homogenates when used at concentrations of 5 and 10 μM. It reduces the synthesis of glucosylceramide, increases cellular ceramide, and induces cell cycle arrest in vitro. The ability to inhibit glucosylceramide synthase has been found to reside in the D-threo-(1R,2R) enantiomer. The D-threo-PDMP enantiomer is also responsible for inhibition of β-1,4-galactosyltransferase 6 and prevention of lactosylceramide synthesis, which is a promotor of neuroinflammation in mice during chronic experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. DL-threo-PDMP increases amyloid-β (1-42) (Aβ42) and Aβ39 production independent of ceramide metabolism via modulation of γ-secretase activity in HEK293 cells expressing the γ-secretase substrate SC100. [Matreya, LLC. Catalog No. 1719] | [Uses]
DL-threo-PDMP can deplete cells and mice of their glucosphinolipids. | [Biochem/physiol Actions]
Glucosylceramide synthase inhibitor; blocks formation of glucosylceramide from ceramide. |
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Website: |
https://www.sigmaaldrich.cn |
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|